Radiopharm Theranostics Ltd Adr Stock (RADX) Forecast
The Radiopharm Theranostics Ltd Adr (RADX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $12.30, representing a +1,237% increase from the current price of $0.92. The highest analyst price target is $12.20, and the lowest is $12.40.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RADX Price Target
Average 7.83 (+751.14% Upside)
Is Radiopharm Theranostics Ltd Adr (RADX) A Buy Now?
Oscillators
Buy: 1 · Sell: 1 · Neutral: 5Summary: Neutral
Moving Averages
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell
According to our latest analysis, RADX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on RADX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.02 indicates that RADX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 29.95 indicates that RADX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 74.29 indicates that RADX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 29.18 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of -32.08 indicates that RADX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RADX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Radiopharm Theranostics Ltd Adr financial reports and earnings history, Radiopharm Theranostics Ltd Adr (RADX) stock could reach $14.42 by 2030, $111.78 by 2040 and $206.73 by 2050. See the projected annual prices until 2050 of the Radiopharm Theranostics Ltd Adr stock below:
- Radiopharm Theranostics Ltd Adr (RADX) is expected to reach an average price of $66.89 in 2035, with a high prediction of $82.78 and a low estimate of $3.18. This indicates an +7,170% change from the last recorded price of $0.92.
- Radiopharm Theranostics Ltd Adr (RADX) stock is projected to chart a bullish course in 2040, with an average price target of $57.09, representing an +6,106% change from its current level. The forecast ranges from a conservative $57.16 to a sky-high $111.78.
- Our analysts predict Radiopharm Theranostics Ltd Adr (RADX) to change +3,070% by 2045, soaring from $29.49 to an average price of $29.17, potentially reaching $97.40. While $29.49 is the low estimate, the potential upside is significant.
- Radiopharm Theranostics Ltd Adr (RADX) stock is expected to climb by 2050, reaching an average of $181.27, a +19,603% change from its current level. However, a wide range of estimates exists, with high and low targets of $206.73 and $10.17, respectively, highlighting the market's uncertainty.
Radiopharm Theranostics Ltd Adr Stock (RADX) Year by Year Forecast
Radiopharm Theranostics Ltd Adr Stock (RADX) Price Forecast for 2026
The predicted value for Radiopharm Theranostics Ltd Adr (RADX) in 2026 is set at an average of $5.00. Estimates vary from a peak of $32.81 to a trough of $0.82, indicating an +443.50% surge from the present price of $0.92.
Radiopharm Theranostics Ltd Adr Stock (RADX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Radiopharm Theranostics Ltd Adr (RADX) is $7.57, with a high forecast of $11.42 and a low forecast of $3.46. This indicates an +723.33% increase from the last price of $0.92.
Radiopharm Theranostics Ltd Adr Stock (RADX) Price Forecast for 2028
In 2028, Radiopharm Theranostics Ltd Adr (RADX) is projected to reach an average price of $1.20, with a high projection of $7.35 and a low estimate of $0.0731. This indicates an +30.35% rise from the last price of $0.92.
Radiopharm Theranostics Ltd Adr Stock (RADX) Price Forecast for 2029
The 2029 price forecast for Radiopharm Theranostics Ltd Adr Stock (RADX) is $22.73 on average, with a high prediction of $29.94 and a low estimate of $0.1791. This represents an +2,370% increase from the previous price of $0.92.
Radiopharm Theranostics Ltd Adr Stock (RADX) Price Forecast for 2030
Radiopharm Theranostics Ltd Adr Stock (RADX) is expected to reach an average price of $7.96 in 2030, with a high forecast of $14.42 and a low forecast of $2.75. This signifies an +765.23% surge from the last price of $0.92.
